American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: Comment on the article by Singh et al

被引：12

作者：

Boers, Maarten ^{[1
]}

Kirwan, John Richard ^{[2
]}

Bijlsma, Johannes W. J. ^{[3
]}

机构：

[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England

[3] Univ Med Ctr, Utrecht, Netherlands

来源：

ARTHRITIS CARE & RESEARCH | 2012年 / 64卷 / 10期

关键词：

MODIFYING ANTIRHEUMATIC DRUGS; ARTHRITIS; RECOMMENDATIONS; INCLUSION;

D O I：

10.1002/acr.21770

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1622 / 1622

页数：1

共 6 条

[1]

Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis A Randomized Trial [J].

Bakker, Marije F. ;

Jacobs, Johannes W. G. ;

Welsing, Paco M. J. ;

Verstappen, Suzanne M. M. ;

Tekstra, Janneke ;

Ton, Evelien ;

Geurts, Monique A. W. ;

van der Werf, Jacobine H. ;

van Albada-Kuipers, Grietje A. ;

Jahangier-de Veen, Zalima N. ;

van der Veen, Maaike J. ;

Verhoef, Catharina M. ;

Lafeber, Floris P. J. G. ;

Bijlsma, Johannes W. J. .

ANNALS OF INTERNAL MEDICINE, 2012, 156 (05) :329-U138

[2]

Combination Therapy Including Glucocorticoids: The New Gold Standard for Early Treatment in Rheumatoid Arthritis? [J].

Kirwan, John Richard .

ANNALS OF INTERNAL MEDICINE, 2012, 156 (05) :390-391

[3]

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis [J].

Saag, Kenneth G. ;

Teng, Gim Gee ;

Patkar, Nivedita M. ;

Anuntiyo, Jeremy ;

Finney, Catherine ;

Curtis, Jeffrey R. ;

Paulus, Harold E. ;

Mudano, Amy ;

Pisu, Maria ;

Elkins-Melton, Mary ;

Outman, Ryan ;

Allison, Jeroan J. ;

Almazor, Maria Suarez ;

Bridges, S. Louis, Jr. ;

Chatham, W. Winn ;

Hochberg, Marc ;

Maclean, Catherine ;

Mikuls, Ted ;

Moreland, Larry W. ;

O'Dell, James ;

Turkiewicz, Anthony M. ;

Furst, Daniel E. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (06) :762-784

[4]

Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: comment on the article by Saag et al Reply [J].

Saag, Kenneth G. ;

Furst, Daniel E. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (01) :142-142

[5]

2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis [J].

Singh, Jasvinder A. ;

Furst, Daniel E. ;

Bharat, Aseem ;

Curtis, Jeffrey R. ;

Kavanaugh, Arthur F. ;

Kremer, Joel M. ;

Moreland, Larry W. ;

O'Dell, James ;

Winthrop, Kevin L. ;

Beukelman, Timothy ;

Bridges, S. Louis, Jr. ;

Chatham, W. Winn ;

Paulus, Harold E. ;

Suarez-Almazor, Maria ;

Bombardier, Claire ;

Dougados, Maxime ;

Khanna, Dinesh ;

King, Charles M. ;

Leong, Amye L. ;

Matteson, Eric L. ;

Schousboe, John T. ;

Moynihan, Eileen ;

Kolba, Karen S. ;

Jain, Archana ;

Volkmann, Elizabeth R. ;

Agrawal, Harsh ;

Bae, Sangmee ;

Mudano, Amy S. ;

Patkar, Nivedita M. ;

Saag, Kenneth G. .

ARTHRITIS CARE & RESEARCH, 2012, 64 (05) :625-639

[6]

van Tuyl LHD, 2009, ARTHRIT RHEUM-ARTHR, V61, P141, DOI [10.1002/art.2423l, 10.1002/art.24231]

← 1 →